# Study Evaluating the Safety and Tolerability of L-377202

> **NCT00987753** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Alabama at Birmingham** · enrollment: 13 (actual)

## Conditions studied

- Hormone Refractory Prostate Cancer
- Prostate Cancer

## Interventions

- **DRUG:** L-377202

## Key facts

- **NCT ID:** NCT00987753
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-03
- **Primary completion:** 2000-09
- **Final completion:** 2001-11
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2023-05-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00987753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00987753, "Study Evaluating the Safety and Tolerability of L-377202". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00987753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*